GB2148713A — Pharmaceutical composition and food product comprising higher fatty acids
Assigned to Century Laboratories Inc · Expires 1985-06-05 · 41y expired
What this patent protects
A pharmaceutical composition includes a combination of eicosapentaenoic acid and/or docosahexaenoic acid together with one or more of dihomo- gamma -linolenic acid, cis-linoleic acid and gamma -linolenic acid. This particular combination of fatty acids may also be administered in…
USPTO Abstract
A pharmaceutical composition includes a combination of eicosapentaenoic acid and/or docosahexaenoic acid together with one or more of dihomo- gamma -linolenic acid, cis-linoleic acid and gamma -linolenic acid. This particular combination of fatty acids may also be administered in the form of a food product such as margarine or cooking oil. The composition causes lowering of blood cholesterol and triglyceride levels. The fatty acids used in this composition may be separated from mixtures thereof or from natural sources thereof by iodinating the double bonds in the starting fat or oil, saponifying, extracting the iodinated fatty acids, methylating and separating by column chromatography, and then deiodinating.
Drugs covered by this patent
- Vascepa (ICOSAPENT ETHYL) · Amarin Pharms
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.